Archean Chemical Industries

    ACI
    Chemicals
    ₹435.95
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹5,382 Cr

    P/E
    53.69
    Day range
    ₹432.85 – ₹439.30
    52-week range
    ₹413.80 – ₹639.80
    Volume
    80,627
    Open
    ₹437.90
    Prev close
    ₹439.50

    Latest results · Q2 FY27(consolidated)Revenue ₹297 Cr+27.5%Profit ₹31 Cr+7.9%Margin 10.5%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 37 / 100

    Factor percentiles

    Value35
    Quality34
    Momentum17
    Low volatility63

    Derived metrics

    Earn. yield
    1.9%
    Graham no.
    ₹166.44
    vs Graham
    -61.8%
    ROE ÷ P/B
    1.9%
    12-1 mom.
    -24.1%
    Return / vol
    -0.95
    Magic Formula
    #564
    Piotroski
    2/6
    FCF yield
    -4.5%
    PEG
    6.80

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 44 in Chemicals
    Largest Chemicals companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Solar IndustriesSOLARINDS₹1.68 L Cr74.0422.1932.5%38.0%29.0%0.23+69.0%
    Pidilite IndustriesPIDILITIND₹1.56 L Cr58.1214.0524.0%31.0%20.0%0.03+20.9%
    SRF LtdSRF₹72,471 Cr31.754.8013.8%15.0%19.0%0.35+34.7%
    Linde IndiaLINDEINDIA₹58,548 Cr118.4613.4213.6%18.0%32.0%0.23+12.3%
    Coromandel InternationalCOROMANDEL₹57,701 Cr37.014.3016.1%22.0%9.0%0.12+6.6%
    Gujarat FluorochemicalsFLUOROCHEM₹52,952 Cr78.396.177.6%10.0%27.0%0.28+45.5%
    Navin Fluorine InternationalNAVINFLUOR₹52,759 Cr57.9511.3720.1%21.0%34.0%0.28+57.1%
    Archean Chemical IndustriesACI₹5,382 Cr53.692.865.5%7.0%24.0%0.28+27.5%
    Sector median₹13,505 Cr31.752.869.9%12.0%15.7%0.27+21.5%

    Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 8h ago

    Headlines about Archean Chemical Industries from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    53.9
    EPS (TTM)
    ₹7.89
    Price / Book
    2.74
    ROE (FY26)
    5.5%
    ROCE (latest year)
    7%
    Dividend yield
    0.57%

    Moving averages (NSE)

    20-day
    ₹444.66
    Price below
    50-day
    ₹463.15
    Price below
    200-day
    ₹532.04
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    -9.1%
    Profit 3Y CAGR
    -35.0%
    Revenue YoY (Sep 2026)
    +27.5%
    Profit YoY (Sep 2026)
    +6.9%
    Operating margin
    24.0%
    Net margin
    10.4%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr200 Cr400 Cr600 Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%20%40%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • DII
    • Public
    • FII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2018 (S)Mar 2019 (S)Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-500 Cr-250 Cr0 Cr250 Cr500 Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY19FY22FY23FY24FY25FY260%200%400%600%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    -500 Cr0 Cr500 Cr1K Cr1.5K Cr2K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2019 (S)Mar 2021 (S)Mar 2022Mar 2023Mar 2024Mar 2025Sep 20260x10x20x

    Dividends per share

    ₹ by fiscal year of the ex-date; the latest year runs to date.

    FY25FY26FY27₹0₹1₹2₹3

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales413284213240242346292233255301327297
    YoY Sales growth—-26-38-17-41——-3—-13——
    Expenses267197141166162257214171200257260227
    Operating Profit1458771758088786354446770
    OPM %35%31%33%31%33%26%27%27%21%15%21%24%
    Other Income91210-2998867564
    Interest2223305641055
    Depreciation181819192021232424232324
    Profit before tax1358061236675584033164446
    Tax %25%28%26%31%27%28%31%27%28%23%31%32%
    Net Profit1025845164854402924123031
    EPS in Rs₹8.23₹4.67₹3.64₹1.28₹3.89₹4.34₹3.26₹2.36₹1.91₹1.09₹2.49₹2.60

    From company filings, updated 19 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days43

    -6 days since Mar 2022

    Inventory Days1221

    +691 days since Mar 2024

    Days Payable598

    +182 days since Mar 2024

    Cash Conversion Cycle666

    +617 days since Mar 2022

    Working Capital Days11

    -38 days since Mar 2022

    Strengths, risks & growth

    Archean Chemical Industries Limited is India's largest exporter of bromine and industrial salt in Fiscal 2021. The company is the leading specialty marine chemical manufacturer in India and is focused on producing and exporting bromine, industrial salt, and sulphate of potash to customers around the world. [1]

    Strengths

    • Company has been maintaining a healthy dividend payout of 21.1%
    • Company's working capital requirements have reduced from 49.5 days to 10.8 days

    Risks

    • Company has a low return on equity of 11.0% over last 3 years.

    Compounded Sales Growth

    10 Years
    —
    5 Years
    —
    3 Years
    -9%
    TTM
    +6%

    Compounded Profit Growth

    10 Years
    —
    5 Years
    —
    3 Years
    -35%
    TTM
    -42%

    Stock Price CAGR

    10 Years
    —
    5 Years
    —
    3 Years
    -6%
    1 Year
    -23%

    Return on Equity

    10 Years
    —
    5 Years
    +18%
    3 Years
    +11%
    Last Year
    +5%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter53.43%53.43%53.43%53.43%0.00 pp
    FII11.08%11.09%11.00%10.40%-0.60 pp
    DII25.26%25.83%24.18%21.34%-2.84 pp
    Government0.00%0.00%0.00%0.00%0.00 pp
    Public10.24%9.67%11.40%14.83%+3.43 pp

    Filed with NSE for Sept 2026: promoters 53.43%, public 46.57%

    Analysts & fund holdings

    80%
    80% recommend buy
    5 analysts cover the stock
    Valuation vs Chemicals
    P/E53.7 vs 25.1
    Sector P/B3.02
    Beta0.24

    Who holds the shares, quarter by quarter

    Mutual funds 15.33% (-0.82 pp)
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters53.4%
    • Foreign institutions10.4%
    • Mutual funds15.3%
    • Insurance2.0%
    • Other domestic institutions4.0%
    • Retail11.0%
    • Others3.9%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    SBI Small Cap Fund3.35%0.45%-0.13 pp
    HDFC Manufacturing Fund2.58%1.45%+0.51 pp
    DSP Small Cap Fund2.35%0.63%-0.12 pp
    HDFC Multi Cap Fund1.45%0.42%-0.04 pp
    Nippon India Small Cap Fund1.11%0.08%-0.01 pp

    Scorecard

    Performance
    Low
    Valuation
    High
    Growth
    Low
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 292 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    32.6%
    Downside volatility
    32.6%
    Worst 5% of days
    3.5%
    Average of that tail
    4.7%
    Max drawdown (1Y)
    41.8%
    Below its peak
    39.1%

    Against the market

    Beta vs Nifty 50
    0.28
    Correlation
    0.12
    Relative strength (3M)
    -19.3%
    ATR (14)
    3.8%

    Return

    Return 1M
    -8.9%
    Return 3M
    -15.4%
    Return 6M
    -19.2%
    Return 1Y
    -30.9%
    vs 200-day average
    -18.1%

    Momentum

    RSI (14)
    43.5
    MACD histogram
    1.41
    Stochastic %K
    43.3
    ADX (14)
    13.1
    +DI / −DI
    25.7 / 19.3
    Money flow index
    62.7

    Participation

    Delivery (20d avg)
    49.6%
    vs its 60-day baseline
    -3.3 pts
    Volume vs 20-day
    -0.4σ
    Close vs day's VWAP
    -0.1%
    52-week position
    7 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 30 Sept 2026.

    Computed

    Piotroski F-Score

    2 of 6 tested

    • Return on assets positive — passed
    • Operating cash flow positive — not testableno cash flow statement for this period
    • Return on assets improving — failed
    • Cash flow exceeds profit — not testableneeds cash flow and profit against assets
    • Debt to assets falling — failed
    • Current ratio improving — failed
    • No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
    • Operating margin improving — failed
    • Asset turnover improving — passed
    Free cash flow
    -₹243 Cr
    FCF yield
    -4.5%
    Cash conversion
    1.32
    Accruals ratio
    -0.013
    Net debt
    ₹503 Cr
    Net debt / equity
    0.26
    EV / sales
    4.99
    PEG
    6.80
    Capex intensity
    35.4%
    Revenue CAGR
    27.5%
    Profit CAGR
    7.9%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Insider trades

    Last 12 months, market trades
    No market trades
    0 buys · ₹0
    0 sells · ₹0
    Latest insider trades disclosed to NSE
    PersonTypeSharesValueDisclosed
    Rajeev Kumar
    Employees/Designated Employees · ESOP
    Buy6,142₹12,28417 Nov 2025

    Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.

    Corporate actions

    • dividend
      ₹2.50

      Dividend - Rs 2.50 Per Share

      5 Jun 2026
      ex-date
    • dividend
      ₹3.00

      Dividend - Rs 3 Per Share

      26 May 2025
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 1 Per Share

      21 Jun 2024
      ex-date
    • dividend
      Not available — not reported in this filing

      Interim Dividend - Re 1 Per Share

      14 Feb 2024
      ex-date
    • dividend
      Not available — not reported in this filing

      Interim Dividend - Re 1 Per Share

      17 Nov 2023
      ex-date
    • dividend
      ₹2.50

      Dividend - Rs 2.50 Per Share

      21 Jul 2023
      ex-date

    Company announcements

    Company UpdatePrice-sensitive
    Announcement under Regulation 30 (LODR)-Credit Rating

    Credit Rating

    Board MeetingPrice-sensitive
    Board Meeting Intimation for Intimation Of Board Meeting

    Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Un-Audited ....

    Insider Trading / SAST
    Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP

    Insider Trading / SAST
    Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP

    Company Update
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

    Insider Trading / SAST
    Closure of Trading Window
    Insider Trading / SAST
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 23, 2026 for Chemikas Speciality LLP

    Insider Trading / SAST
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas Speciality LLP

    Insider Trading / SAST
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund

    Company Update
    Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    Earnings call Transcript

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Earnings Call Recording

    Company Update
    Announcement under Regulation 30 (LODR)-Investor Presentation

    Investor Presentation

    Company Update
    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Publication of Financial Result

    Insider Trading / SAST
    Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 31, 2026 for Chemikas Speciality LLP

    Result
    Board Meeting Outcome - 30.07.2026

    Please find enclosed the Board Meeting Outcome - 30.07.2026 along with the Unaudited Financial Results for the quarter ended June 30, 2026.

    Filed with BSE (scrip 543657); the last 45 days. Documents open at bseindia.com.

    Documents

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 30 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Archean Chemical Industries: common questions

    Answered from the figures on this page.

    Archean Chemical Industries last traded at ₹435.95 (NSE, as of 18 Nov 2026). The last session moved it down 0.81%.

    Archean Chemical Industries is valued at about ₹5,382 crore (NSE, as of 18 Nov 2026).

    Archean Chemical Industries trades at a price-to-earnings ratio of 53.69 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Archean Chemical Industries has traded between ₹413.80 and ₹639.80 over the past 52 weeks, to 18 Nov 2026. It is currently 10% of the way up that range.

    Archean Chemical Industries (ACI) is classified under Chemicals on this site's screener.